Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Krishna K Gaddam

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Journal of the American Society of Hypertension : JASH|April 23, 2010
Diastolic dysfunction and heart failure with preserved ejection fraction: rationale for RAAS antagonist/CCB combination therapyKrishna K Gaddam, Suzanne Oparil
Current Opinion in Nephrology and Hypertension|August 13, 2008
Renin inhibition: should it supplant ACE inhibitors and ARBS in high risk patients?Krishna K Gaddam, Suzanne Oparil
Congestive Heart Failure (Greenwich, Conn.)|March 22, 2012
Developments in heart failure 2011Krishna K Gaddam, Hector Ventura
Congestive Heart Failure (Greenwich, Conn.)|April 1, 2011
Developments in heart failure 2010Krishna K Gaddam, Tara Jarreau, Hector Ventura
Journal of Clinical Hypertension (Greenwich, Conn.)|March 11, 2008
Mechanisms and treatment of resistant hypertensionEduardo Pimenta, Krishna K Gaddam, Suzanne Oparil
Expert Opinion on Emerging Drugs|February 7, 2009
Emerging diuretics for the treatment of heart failureYabiz Sedghi, Krishna K Gaddam, Hector O Ventura
Future Cardiology|December 22, 2011
Antihypertensive therapy versus alternative therapeutic options for prehypertension: an evidence-based approachKrishna K Gaddam, Hector Ventura, Carl J Lavie
Current Hypertension Reports|February 8, 2011
Metabolic syndrome and heart failure--the risk, paradox, and treatmentKrishna K Gaddam, Hector O Ventura, Carl J Lavie
Ochsner Journal|May 24, 2011
Advanced heart failure and management strategiesKrishna K Gaddam, Pridhvi Yelamanchili, Yabiz Sedghi, et al.
Expert Review of Cardiovascular Therapy|May 24, 2006
Aldosterone antagonists: effective add-on therapy for the treatment of resistant hypertensionKrishna K Gaddam, Monique N Pratt-Ubunama, David A Calhoun
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Journal of the American Society of Hypertension : JASH|April 23, 2010
Diastolic dysfunction and heart failure with preserved ejection fraction: rationale for RAAS antagonist/CCB combination therapyKrishna K Gaddam, Suzanne Oparil
Current Opinion in Nephrology and Hypertension|August 13, 2008
Renin inhibition: should it supplant ACE inhibitors and ARBS in high risk patients?Krishna K Gaddam, Suzanne Oparil
Congestive Heart Failure (Greenwich, Conn.)|March 22, 2012
Developments in heart failure 2011Krishna K Gaddam, Hector Ventura
Congestive Heart Failure (Greenwich, Conn.)|April 1, 2011
Developments in heart failure 2010Krishna K Gaddam, Tara Jarreau, Hector Ventura
Journal of Clinical Hypertension (Greenwich, Conn.)|March 11, 2008
Mechanisms and treatment of resistant hypertensionEduardo Pimenta, Krishna K Gaddam, Suzanne Oparil
Expert Opinion on Emerging Drugs|February 7, 2009
Emerging diuretics for the treatment of heart failureYabiz Sedghi, Krishna K Gaddam, Hector O Ventura
Future Cardiology|December 22, 2011
Antihypertensive therapy versus alternative therapeutic options for prehypertension: an evidence-based approachKrishna K Gaddam, Hector Ventura, Carl J Lavie
Current Hypertension Reports|February 8, 2011
Metabolic syndrome and heart failure--the risk, paradox, and treatmentKrishna K Gaddam, Hector O Ventura, Carl J Lavie
Ochsner Journal|May 24, 2011
Advanced heart failure and management strategiesKrishna K Gaddam, Pridhvi Yelamanchili, Yabiz Sedghi, et al.
Expert Review of Cardiovascular Therapy|May 24, 2006
Aldosterone antagonists: effective add-on therapy for the treatment of resistant hypertensionKrishna K Gaddam, Monique N Pratt-Ubunama, David A Calhoun
Pageof 3